The first case harbored compound heterozygous DUOX2 mutations (p.G94S, p.F966Sfs*29), of which p.F966Sfs*29 is a known pathogenic mutation and likely to be the main cause for CH in this case. Here, DUOX2 is linked to cyclic hematopoiesis.